Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment
Crossref DOI link: https://doi.org/10.1007/s00280-017-3431-5
Published Online: 2017-09-20
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Kyung
Jha, Reena
Prins, Petra A.
Wang, Hongkun
Chacha, Monica
Hartley, Marion L.
He, Aiwu Ruth http://orcid.org/0000-0002-2104-0816
License valid from 2017-09-20